Executive Committee
About Us Committees ul > .bdt-post-list-item; delay: 350;”> Executive Committee Patient Advisory Board Coordinating Center
About Us Committees ul > .bdt-post-list-item; delay: 350;”> Executive Committee Patient Advisory Board Coordinating Center
About Us Committees ul > .bdt-post-list-item; delay: 350;”> Executive Committee Patient Advisory Board Coordinating Center
This toolkit contains a variety of resources to assist providers in giving their patients the information
Introduction to INHALE Current Members ul > .bdt-post-list-item; delay: 350;”> 2024 Meetings Member PO Materials
General Update Flovent HFA and Flovent Diskus are inhaled corticosteroid medicines used as a controller
Introduction to INHALE Current Members ul > .bdt-post-list-item; delay: 350;”> 2024 Collaborative Meetings Member PO
Introduction to INHALE Current Members ul > .bdt-post-list-item; delay: 350;”> 2024 Meetings Member PO Materials
The INHALE Patient Advisory Board assembled for its first virtual meeting on November 9th. At this meeting,
Introduction to INHALE Current Members ul > .bdt-post-list-item; delay: 350;”> 2024 Meetings Member PO Materials
Description: Our short-acting beta agonist use (dispensed) measure uses claims data to determine the percentage
INHALE prepares regular PO and Clinical level newsletters that contain:
Support for the INHALE CQI is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs.
Although Blue Cross Blue Shield of Michigan and the INHALE CQI work in partnership, the opinions, beliefs, and viewpoints expressed by INHALE CQI do not necessarily reflect the opinions, beliefs, and viewpoints of BCBSM or any of its employees.